ICT-107 & Speaking About Brain Tumor Awareness
by Rob Sutter
Therapies are going to find their home in the realm of brain tumor awareness, which is something that very few individuals will be able to argue against. There will be procedures that will come about and it seems as though various drugs will make sure that this happens in the long term. That being said, what can be said about the ICT-107 vaccine? To me, this is something that can prove useful, if a specific recent report is to be taken into account in the long term.
There was a written report on Medical News Today that spoke about this condition, which is something that should be gone about in detail. Glioblastoma multiforme seems to be the name of the game, which isn't hard to see why once you understand the details associated with it. After all, this particular type of brain tumor has been viewed as the most common and aggressive in this field. More details can be picked up on by referring to strong organizations such as <a href="https://www.facebook.com/VoicesAgainstBrainCancer">Voices against Brain Cancer</a>.
The <a href="http://www.usatoday.com/videos/news/2013/09/08/2782553">cells</a>, as far as this condition is concerned, are ones that seem to regenerate rather quickly even after invasive surgery is done. This is mostly due to the idea that the cells feed off of a consistent blood stream, so it is clear that there is a need for deeper procedures to be seen. This was something that was told by the American Brain Tumor Association and it was also noted that the risk increases with age, more so with men and women. However, this condition can come about in anyone, regardless of such factors.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
Contact <a href="http://www.voicesagainstbraincancer.org/about-us/garylichtenstein/">Voices Against Brain Cancer</a> if you're looking for some additional information about <a href="http://www.voicesagainstbraincancer.org/">brain tumor research</a> and awareness.. Unique version for reprint here: <a href="http://www.uberarticles.com/home.php?id=1933347&p=56131">ICT-107 & Speaking About Brain Tumor Awareness</a>.
---------------------------------------------------
You are receiving this because you signed up for it on 2011-11-27 from IP 188.29.196.69
To fine-tune your selection of which articles to receive, just login here:
http://www.uniquearticlewizard.com/bloggers/
using your username:
To unsubscribe please use the following link:
http://www.uniquearticlewizard.com/unsubscribe.php?mail=nightcabcontroller.sante1@blogger.com&code=f1f5baef192407461ee7ffe7468a92d2
---------------------------------------------------
---------------------------------
New Unique Article!
Title: ICT-107 & Speaking About Brain Tumor Awareness
Author: Rob Sutter
Email: seo@fishbat.com
Keywords: Voices Against Brain Cancer, brain tumor, brain tumor awareness, information about brain tumors, brain cancer awareness, health, medical news, disease illness, glioblastoma
Word Count: 468
Category: Disease & Illness
---------------------------------
No comments:
Post a Comment